Teva to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and 2021 Financial Guidance at 8 a.m. ET on February 10, 2021 | Business Wire
News & Media
Teva Canada Welcomes Public Drug Plan Reimbursement by Alberta, Saskatchewan, Québec, Veteran Affairs Canada and the Non-Insured Health Benefits Program for Patients prescribed AJOVY® (fremanezumab) for the Preventive Treatment of Migraine in
Teva responds to Mylan backlash with planned launch of generic EpiPen | Healthcare IT News
Teva enters opioid settlement agreement with US state Rhode Island
Pharmaceutical Company Reaches Settlement With Oklahoma In Opioid Case : NPR
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
$225 Million Settlement Reached With Teva Pharmaceutical Industries Is Fourth Opioid Settlement For Texas - Ksst Radio
Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults | Business Wire
TEVA PHARMACEUTICALS USA, INC: Teva Announces Updated Indication and Vial Presentation for GRANIX® (tbo-filgrastim) Injection in United States | American Pharmacy News
Teva Becomes First Pharmaceutical Company to Execute Sustainability-Linked Bond Tied to Both Climate and Access to Medicine Targets | News Direct
Top Factors Driving the Injectable Drug Delivery Formulation Market| A comprehensive study on Key Players- Gerresheimer, Pfizer, Teva Pharmaceutical Industries « MarketersMEDIA – Press Release Distribution Services – News Release Distribution Services
Teva 'optimistic' opioid settlement could come within year following historic $26B deal with Johnson & Johnson, 3 distributors | Fierce Pharma
California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post
Teva Pharmaceutical Industries Limited Blog | Talkmarkets | Page 1
Teva's AJOVY® Receives EU Approval Offering Patients the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Prophylaxis of Migraine in Adults | Nasdaq
Teva Pharmaceutical Industries Ltd. (TEVA) Stock Price, Quote & News | Stock Analysis
Bristol Myers Squibb's Revlimid finally faces competition in the U.S. with Teva's generic launch | Fierce Pharma
Insilico collaborates with Teva on AI system | EurekAlert!
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva Unveils New Spring 2022 Collection
Teva CEO stands down during troubled times - MedCity News
Teva Generic Medicines Saved the United States $28.8 Billion in 2020, and a Total of $43.1 Billion Across Major Markets, According to Independent Analysis
Teva: A Complete Overview (NYSE:TEVA) | Seeking Alpha
Teva settles with Rhode Island on opioid-related claims
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva's pursuit of J&J boosted by FDA acceptance of filing for approval of long-acting schizophrenia drug | Fierce Pharma
